Zentalis Pharmaceuticals's total assets for Q3 2025 were $327.25M, a decrease of -6.95% from the previous quarter. ZNTL total liabilities were $74.38M for the fiscal quarter, a -3.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.